NASDAQ:PCRX - US6951271005 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 705.85M | 700.97M | 674.98M | 666.80M | 541.50M | |||
Cost Of Goods | 153.92M | 170.43M | 184.67M | 199.30M | 140.30M | |||
Gross Profit | 551.93M | 530.54M | 490.31M | 467.50M | 401.30M | |||
Operating Expenses | 482.03M | 432.96M | 402.99M | 396.60M | 268.40M | |||
Research and Development | 95.44M | 81.58M | 76.26M | 84.80M | 55.50M | |||
Selling, General, and Administrative Expenses | 329.30M | 294.10M | 269.44M | 254.50M | 199.30M | |||
Operating Income | 69.89M | 97.57M | 87.32M | 70.90M | 132.80M | |||
Interest Income/Expense | 4.30M | 3.12M | -8.86M | -35.40M | -30.90M | |||
Other Income/Expense | -6.51M | -373.00K | -186.00K | -11.30M | -2.70M | |||
Non Recurring Items | -174.23M | -163.43M | -16.57M | -10.90M | -42.90M | |||
Income Before Taxes | -106.55M | -63.11M | 61.70M | 13.30M | 56.40M | |||
Income Tax | 20.91M | 36.45M | 19.75M | -2.60M | 14.40M | |||
Net Income | -127.46M | -99.56M | 41.95M | 15.90M | 42.00M | |||
EBITDA | 159.88M | 176.36M | 162.90M | 162.40M | 161.30M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.77 | -2.15 | 0.80 | 0.34 | 0.92 | |||
Non GAAP EPS | 3.06 | 3.21 | 2.92 | 2.59 | 2.99 | |||
Statistics | ||||||||
Gross Profit Margin | 78.19% | 75.69% | 72.64% | 70.11% | 74.11% | |||
Profit Margin | -18.06% | -14.20% | 6.22% | 2.38% | 7.76% | |||
Operating Profit Margin | 9.90% | 13.92% | 12.94% | 10.63% | 24.52% |
All data in USD